{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-08-04",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "effective_time": "20151124",
      "instructions_for_use": [
        "Testagen(R) TDS Testosterone 5% Instructions for use To be applied in accordance with enclosed instructions."
      ],
      "package_label_principal_display_panel": [
        "Testagen TDS Testosterone 5% Principal Display panel - Clinical trial materials For Clinical Trial Use Only EudraCT No: 2013-001766-42 PARC-Testosterone-D-01/09/13 Subject number: S/R_____ For topical application To be applied in accordance with enclosed instructions Investigator: Prof R Langford Use by: 07 / 2017 Batch no: TDST-004 Keep out of the reach of and avoid contact with women & children Store at room temp. TLC Advanced Therapies Centre Pharm. Caution – New Drug – Limited by Law to Investigational Use See Image CDER Testagen Label Image of sample label"
      ],
      "spl_product_data_elements": [
        "Testagen Testosterone (1,2,6,7-3H)TESTOSTERONE (1,2,6,7-3H)TESTOSTERONE"
      ],
      "set_id": "44e4944f-3e80-5b60-e054-00144ff8d46c",
      "id": "44e4944f-3e81-5b60-e054-00144ff8d46c",
      "openfda": {},
      "version": "4"
    }
  ]
}